JP2001513111A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513111A5 JP2001513111A5 JP1998538595A JP53859598A JP2001513111A5 JP 2001513111 A5 JP2001513111 A5 JP 2001513111A5 JP 1998538595 A JP1998538595 A JP 1998538595A JP 53859598 A JP53859598 A JP 53859598A JP 2001513111 A5 JP2001513111 A5 JP 2001513111A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/807,992 US6022541A (en) | 1991-10-18 | 1997-03-03 | Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| US08/807,992 | 1997-03-03 | ||
| PCT/US1998/003765 WO1998039037A1 (en) | 1997-03-03 | 1998-02-26 | Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001513111A JP2001513111A (ja) | 2001-08-28 |
| JP2001513111A5 true JP2001513111A5 (https=) | 2005-10-06 |
Family
ID=25197602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53859598A Ceased JP2001513111A (ja) | 1997-03-03 | 1998-02-26 | 腫瘍付随血管（ｔｕｍｏｒ−ａｓｓｏｃｉａｔｅｄ ｂｌｏｏｄ ｖｅｓｓｅｌｓ）上の血管透過因子の複数のエピトープに結合する同時インビボイムノコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6022541A (https=) |
| EP (1) | EP0968002A4 (https=) |
| JP (1) | JP2001513111A (https=) |
| AU (1) | AU722722B2 (https=) |
| CA (1) | CA2283295C (https=) |
| WO (1) | WO1998039037A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6749853B1 (en) * | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
| US5965132A (en) * | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
| US6824986B1 (en) * | 1997-10-06 | 2004-11-30 | University Of Cincinnati | Methods for measuring in vivo cytokine production |
| IL128852A0 (en) * | 1999-03-05 | 2000-01-31 | Compugen Ltd | Novel nucleic acid and amino acid sequences |
| US6783954B2 (en) * | 1999-03-05 | 2004-08-31 | Compugen Ltd. | VEGF nucleic acid and amino acid sequences |
| EP1179541B1 (en) | 1999-04-28 | 2004-06-16 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| US6703020B1 (en) | 1999-04-28 | 2004-03-09 | Board Of Regents, The University Of Texas System | Antibody conjugate methods for selectively inhibiting VEGF |
| JP4343473B2 (ja) * | 1999-06-21 | 2009-10-14 | 日本メジフィジックス株式会社 | 血漿蛋白質に結合親和性を有する薬剤の投与方法並びに当該投与方法に用いられる製剤 |
| AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| FR2799465B1 (fr) * | 1999-10-12 | 2004-02-13 | Centre Nat Rech Scient | Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire |
| US6974791B2 (en) * | 2000-03-16 | 2005-12-13 | The University Of Pittsburgh | Endothelial specific targeting |
| US7097840B2 (en) | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| WO2003028840A2 (en) * | 2001-09-27 | 2003-04-10 | Board Of Regents, The University Of Texas System | Combined compositions and methods for tumor vasculature coagulation and treatment |
| AU2002362646A1 (en) * | 2001-10-09 | 2003-04-22 | The Johns Hopkins University | A phosphatase associated with metastasis |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| US8080253B2 (en) * | 2004-02-05 | 2011-12-20 | The Ohio State University Research Foundation | Chimeric VEGF peptides |
| CN101970486A (zh) * | 2007-10-25 | 2011-02-09 | 布里斯托尔大学 | 特异于血管内皮生长因子(vegf)的促血管发生同工型的抗体 |
| NZ602675A (en) | 2008-03-18 | 2014-03-28 | Genentech Inc | Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
| WO1993008210A1 (en) * | 1991-10-18 | 1993-04-29 | Beth Israel Hospital Association | Vascular permeability factor targeted compounds |
| US5776427A (en) * | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| AU702250B2 (en) * | 1994-07-11 | 1999-02-18 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
-
1997
- 1997-03-03 US US08/807,992 patent/US6022541A/en not_active Expired - Fee Related
-
1998
- 1998-02-26 EP EP98912888A patent/EP0968002A4/en not_active Withdrawn
- 1998-02-26 WO PCT/US1998/003765 patent/WO1998039037A1/en not_active Ceased
- 1998-02-26 JP JP53859598A patent/JP2001513111A/ja not_active Ceased
- 1998-02-26 CA CA002283295A patent/CA2283295C/en not_active Expired - Fee Related
- 1998-02-26 AU AU67570/98A patent/AU722722B2/en not_active Ceased